Blei F, Karp N, Rofsky N, Rosen R, Greco M A
Department of Pediatrics, NYU Medical Center, New York 10016, USA.
Pediatr Hematol Oncol. 1998 Jul-Aug;15(4):295-305. doi: 10.3109/08880019809014013.
We present the management challenge provided by a patient with kaposiform hemangioendothelioma associated with Kasabach-Merritt phenomenon. A female child presented at 14 months of age with an ecchymotic swelling of her right upper arm and axilla. Subsequently, she developed profound thrombocytopenia and hypofibrinogenemia (Kasabach-Merritt phenomenon). Biopsy of the lesion revealed kaposiform hemangioendothelioma, which has been reported as the predominant pathologic diagnosis associated with Kasabach-Merritt phenomenon. To achieve involution of the lesion and preserve function of the arm, the following interventions were involved: embolization, systemic interferon, cyclophosphamide, epsilon aminocaproic acid, and compression therapy. The clinical management of this patient was formidable until we arrived at the proper combination of therapies. Multimodal intervention may be required to manage fastidious hemangioendotheliomas of childhood, achieve clinical improvement, and prevent further morbidity.
我们介绍了一名患有与卡萨巴赫-梅里特现象相关的卡波西样血管内皮瘤患者所带来的管理挑战。一名14个月大的女童因右上臂和腋窝瘀血性肿胀就诊。随后,她出现了严重的血小板减少和低纤维蛋白原血症(卡萨巴赫-梅里特现象)。病变活检显示为卡波西样血管内皮瘤,据报道这是与卡萨巴赫-梅里特现象相关的主要病理诊断。为了使病变消退并保留手臂功能,采取了以下干预措施:栓塞、全身应用干扰素、环磷酰胺、ε-氨基己酸和压迫疗法。在找到合适的治疗组合之前,该患者的临床管理极具挑战性。对于儿童难治性血管内皮瘤,可能需要多模式干预以实现临床改善并预防进一步的发病情况。